N,N-dimethyl-2-[(5-phenyl-1,3,4-oxadiazol-2-yl)sulfanyl]acetamide
Structure Info
- Chemspace ID
- CSSB00026074395 (In-Stock Building Blocks)
- CAS
- 878465-90-8
- MFCD
- MFCD04274259
- IUPAC Name
- N,N-dimethyl-2-[(5-phenyl-1,3,4-oxadiazol-2-yl)sulfanyl]acetamide
- Mol formula
- C12H13N3O2S
- Mol weight
- 263 Da
- Catalog Number(s)
- ArZ-UP780823, CSC026074395, CSCR00020286215, EN300-37785917, PB19583763, Z19506295, s_1626_24364878_22099454, s_1626____24364878____22099454
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.1
- Heavy atoms count
- 18
- Rotatable bond count
- 4
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.25
- Polar surface area (Å)
- 59
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 0
![Chemical structure of N,N-dimethyl-2-[(5-phenyl-1,3,4-oxadiazol-2-yl)sulfanyl]acetamide (C12H13N3O2S) - CSSB00026074395](/st/structure/200/9b56351240c5668af620353bf2f56e19/CN%2528C%2529C%2528%253DO%2529CSC1%253DNN%253DC%2528O1%2529C1%253DCC%253DCC%253DC1.png "C12H13N3O2S")
- Zoom the structure
- CSSB00026074395
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 103.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 156.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 222.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 422.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 541.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 1,063.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,572.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 2,331.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Substructure Analogs
![Chemical structure of 2-{[5-(4-hydroxyphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl}-N,N-dimethylacetamide - CSSB00132551003](/st/structure/200/d9d5f360cc3016a99fa2861bb47dd53f/CN%2528C%2529C%2528%253DO%2529CSC1%253DNN%253DC%2528O1%2529C1%253DCC%253DC%2528O%2529C%253DC1.png)
![Chemical structure of 2-{[5-(4-fluorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl}-N,N-dimethylacetamide - CSSB00104021565](/st/structure/200/a728fcc64cb15fb22322b97f10f74fa9/CN%2528C%2529C%2528%253DO%2529CSC1%253DNN%253DC%2528O1%2529C1%253DCC%253DC%2528F%2529C%253DC1.png)
![Chemical structure of 2-{[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl}-N,N-dimethylacetamide - CSSB00104331067](/st/structure/200/bf58921e63b25848adf561cb0e355d54/CN%2528C%2529C%2528%253DO%2529CSC1%253DNN%253DC%2528O1%2529C1%253DCC%253DC%2528Cl%2529C%253DC1.png)
![Chemical structure of 2-{[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl}-1-(piperidin-1-yl)ethan-1-one - CSSB00046261841](/st/structure/200/2456080d34c4c65f27aab6542a4abdef/CC1%253DCC%253DCC%2528%253DC1%2529C1%253DNN%253DC%2528O1%2529SCC%2528%253DO%2529N1CCCCC1.png)
![Chemical structure of 2-{[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl}-1-(piperidin-1-yl)ethan-1-one - CSSB00046127857](/st/structure/200/faa5f71827c734aa3c466bb37fd38962/CC1%253DCC%253DCC%253DC1C1%253DNN%253DC%2528O1%2529SCC%2528%253DO%2529N1CCCCC1.png)
![Chemical structure of 2-{[5-(2-methylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl}-1-(morpholin-4-yl)ethan-1-one - CSSB00046232691](/st/structure/200/cec1c5c7ed5879b354c6c6dfa8ed5d11/CC1%253DCC%253DCC%253DC1C1%253DNN%253DC%2528O1%2529SCC%2528%253DO%2529N1CCOCC1.png)
![Chemical structure of 2-{[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl}-1-(morpholin-4-yl)ethan-1-one - CSSB00046247445](/st/structure/200/c106a034c1b815de4ad458e516e5aeae/CC1%253DCC%253DC%2528C%253DC1%2529C1%253DNN%253DC%2528O1%2529SCC%2528%253DO%2529N1CCOCC1.png)
